home / stock / fh:cc / fh:cc news

FH:CC News and Press, FILAMENT HEALTH CORP. From 07/13/22

Stock Information
Company Name: FILAMENT HEALTH CORP.
Stock Symbol: FH:CC
Market: AQNC
Menu
FH:CC FH:CC Quote FH:CC Short FH:CC News FH:CC Articles FH:CC Message Board
Get FH:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
FH:CC - FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT

FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT Canada NewsWire Financing led by psychedelic investment fund Negev Capital and leading functional mushroom manufacturer Nammex VANCOUVER, BC , July 13, 2022 /CNW/ - Filament Hea...
FH:CC - FILAMENT HEALTH ISSUED THIRD PATENT BY UNITED STATES PATENT AND TRADEMARK OFFICE

FILAMENT HEALTH ISSUED THIRD PATENT BY UNITED STATES PATENT AND TRADEMARK OFFICE Canada NewsWire The patent describes the extraction and standardization of stable doses of psychedelic compounds VANCOUVER, BC , July 12, 2022 /CNW/ - Filament He...

FH:CC - FILAMENT HEALTH ANNOUNCES FIRST DOSING IN GROUNDBREAKING FDA-APPROVED PSILOCIN CLINICAL TRIAL

FILAMENT HEALTH ANNOUNCES FIRST DOSING IN GROUNDBREAKING FDA-APPROVED PSILOCIN CLINICAL TRIAL Canada NewsWire The trial, conducted at UCSF's TrPR Lab, is first to use naturally derived psychedelic drug candidates and first to directly administer psilocin, the active fo...

FH:CC - Filament Health Announces First Dosing in Groundbreaking FDA-Approved Psilocin Clinical Trial

​​ The trial, conducted at UCSF’s TrPR Lab, is first to use naturally derived psychedelic drug candidates and first to directly administer psilocin, the active form of psilocybin Filament Health Corp. ( OTCQB:FLHLF ) ( NEO:FH ) ( FSE:7Q...
FH:CC - FILAMENT HEALTH ANNOUNCES SIXTH PATENT ISSUANCE

FILAMENT HEALTH ANNOUNCES SIXTH PATENT ISSUANCE Canada NewsWire The patent describes the extraction and standardization of stable doses of psychedelic compounds VANCOUVER, BC , July 6, 2022 /CNW/ - Filament Health Corp. ( OTCQB: FLHLF ...

FH:CC - FILAMENT HEALTH ANNOUNCES PRIVATE PLACEMENT OF UNITS AND CONVERTIBLE DEBENTURE UNITS OF UP TO $2,500,000

FILAMENT HEALTH ANNOUNCES PRIVATE PLACEMENT OF UNITS AND CONVERTIBLE DEBENTURE UNITS OF UP TO $2,500,000 Canada NewsWire Financing driven by psychedelic investment fund Negev Capital and leading functional mushroom manufacturer Nammex VANCOUVER, BC , ...

FH:CC - FILAMENT HEALTH ANNOUNCES ANNUAL GENERAL MEETING VOTING RESULTS

FILAMENT HEALTH ANNOUNCES ANNUAL GENERAL MEETING VOTING RESULTS Canada NewsWire VANCOUVER, BC , June 28, 2022 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural...
FH:CC - FILAMENT HEALTH ANNOUNCES PATIENT DOSING THROUGH HEALTH CANADA SPECIAL ACCESS PROGRAM

FILAMENT HEALTH ANNOUNCES PATIENT DOSING THROUGH HEALTH CANADA SPECIAL ACCESS PROGRAM Canada NewsWire VANCOUVER, BC , June 16, 2022 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage n...

FH:CC - FILAMENT HEALTH CULTIVATES 70TH PSYCHEDELIC MUSHROOM VARIETY AND ANNOUNCES ANNUAL GENERAL MEETING

FILAMENT HEALTH CULTIVATES 70TH PSYCHEDELIC MUSHROOM VARIETY AND ANNOUNCES ANNUAL GENERAL MEETING Canada NewsWire VANCOUVER, BC , June 10, 2022 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clin...

FH:CC - Filament Health and Jaguar Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications

Filament Health and Jaguar Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications Canada NewsWire Drug discovery collaboration will leverage the botanical drug development expertise of both companies VANCOU...
Previous 10 Next 10